These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3528958

  • 1. TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.
    Link H, Kurrle E, Frauer HM, Heil G, Heimpel H, Waller HD, Ostendorf P, Wilms K, Hoelzer D.
    Onkologie; 1986 Jun; 9(3):135-8. PubMed ID: 3528958
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM, Eastern Cooperative Oncology Group Study.
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [Abstract] [Full Text] [Related]

  • 3. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A, German AML Cooperative Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4496-504. PubMed ID: 14673036
    [Abstract] [Full Text] [Related]

  • 4. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D, Scaglione C, Santarelli MT, Sackmann Muriel F, Jiménez E, Pavlovsky S, Bustelo P, Richard L, Kohan R, Kvicala R.
    Sangre (Barc); 1989 Jun 15; 34(3):221-8. PubMed ID: 2669186
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial.
    Rees JK, Gray R.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):32-6. PubMed ID: 3473681
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K, Ritter J, Schellong G, Beck JD, Kabisch H, Lampert F, Creutzig U.
    Klin Padiatr; 1992 Jun 15; 204(4):253-7. PubMed ID: 1518261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
    Creutzig U, Ritter J, Riehm H, Budde M, Schellong G.
    Haematol Blood Transfus; 1987 Jun 15; 30():71-5. PubMed ID: 3305225
    [No Abstract] [Full Text] [Related]

  • 17. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M.
    Wiad Lek; 1995 Jun 15; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM, Grañena A, Rozman C, Urbano-Ispizua A, Bladé J, Carreras E, Cervantes F, Marín P, Sierra J, Nomdedeu B.
    Sangre (Barc); 1990 Feb 15; 35(1):26-32. PubMed ID: 2333581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.